0
Title
User
LIVE NOW
LIVE NOW
Title
User
Sign In
Home
Trending
Sign In
Audios and Videos
Videos
Audios
Channels
Browse Channels
Categories
Acute Lymphoblastic Leukemia
5643
Acute Myelogenous Leukemia
153
Bladder Cancer
51
Bone Metastases
1
Brain Cancer
18
Breast Cancer
130
Business Management
2
Cervical Cancer
2
Chronic Lymphocytic Leukemia
163
Chronic Myelogenous Leukemia
23
Colorectal Cancer
75
Gastrointestinal Cancer
71
General
250
Head and Neck Cancers
35
Hematologic Malignancies
82
Hodgkin Lymphoma
19
Immunotherapy
95
Kidney Cancer
365
Liver Cancer
11
Lymphoma
145
Melanoma and Skin Cancer
51
Multiple Myeloma
347
Myeloproliferative Disease
17
News
127
Non-Hodgkin Lymphoma
52
Non-Small Cell Lung Cancer
266
Other
112
Ovarian Cancer
10
Pancreatic Cancer
55
Patient Resources
27
Prostate Cancer
152
Small Cell Lung Cancer
59
Soft Tissue Sarcoma
9
Supportive Care
39
Testicular Cancer
2
Urology
9
Uterine Cancer
2
About
Contact
00:03:39
TIP or BEP for Intermediate or Poor Risk Testicular Cancer?: Highlights in GU Oncology from ASCO 2018 (BMIC-061)
Dr. Dan Goldstein reviews results of a trial of chemo regimen TIP (paclitaxel, ifosfamide, cisplatin) vs BEP (bleomycin, etoposide, cisplatin) for intermediate/poor risk germ cell tumors, with discussion of outcomes in patients with a p53 mutation.
331 Views
1 year ago
BeaconMedIC
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
Live
Trending
Latest Videos
00:02:24
Molecular aging and p16INK4a in testicular cancer survivors
217 Views
1 year ago
VJOncology
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
00:03:39
TIP or BEP for Intermediate or Poor Risk Testicular Cancer?: Highlights in GU Oncology from ASCO 2018 (BMIC-061)
331 Views
1 year ago
BeaconMedIC
Add to
Want to watch this again later?
Sign in to add this video to a playlist.
Login
